Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment

R. A. Werner, J. S. Schmid, D. O. Muegge, K. Lückerath, T. Higuchi, H. Hänscheid, I. Grelle, C. Reiners, K. Herrmann, A. K. Buck, C. Lapa

Research output: Contribution to journal › Article › peer-review